Psychopharmacology of Human Aggression: Laboratory and Clinical Studies

Don R. Cherek, Oleg V. Tcheremissine and Scott D. Lane

in Biology of Aggression

Published in print September 2005 | ISBN: 9780195168761
Published online May 2009 | e-ISBN: 9780199865444 | DOI:
 							Psychopharmacology of Human Aggression: Laboratory and Clinical Studies

Show Summary Details


This chapter discusses the association between drugs and human aggression, laboratory studies of human aggression, and effects of drugs on human aggression under laboratory conditions. It argues that methodological difficulties often prevent unequivocal interpretations of the outcomes of pharmacological treatments of aggression. Conducting well-designed placebo-controlled studies in an inpatient setting is difficult, as drug-free washout periods may be unsafe for both patients and staff. Thus, it is clinically difficult to assess whether a reduction in aggression is a specific effect of the pharmacological agent or of nonspecific effects of medications such as neuroleptics and benzodiazepines commonly used for the management of specific Axis I and Axis II disorders. Nonpharmacological factors, such as the therapeutic milieu, can affect treatment outcome and should be considered when evaluating the efficacy of a pharmacotherapeutic intervention for aggression.

Keywords: aggressive behavior; drugs; laboratory studies; pharmacological treatments; placebo

Chapter.  15863 words. 

Subjects: Neuroscience

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.